Cholesterol reduction is big business. Pfizer’s Lipitor alone raked in $125 billion between 1996 to 2012. This amount of money can be very corrupting. It’s almost impossible to find experts who are not influenced by money from industry.
If true then aspirins may be just as useful as statins while being cheaper and safer. (But you won't see anyone funding a clinical trial to prove this, any time soon!)